Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
---|---|---|---|---|---|---|
2020 | Tylophorine-based compounds are therapeutic in rheumatoid arthritis by targeting the caprin-1 ribonucleoprotein complex and inhibiting expression of associated c-Myc and HIF-1α. | Lee, YZ; Guo, HC; Zhao, GH; Yang, CW; Chang, HY; Yang, RB ; Chen, L; Lee, SJ | PHARMACOLOGICAL RESEARCH 152, 104581 |